BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21742683)

  • 1. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates from dogs with otitis externa.
    Mekić S; Matanović K; Šeol B
    Vet Rec; 2011 Jul; 169(5):125. PubMed ID: 21742683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J; Walker RD; Blickenstaff K; Bodeis-Jones S; Zhao S
    Vet Microbiol; 2008 Sep; 131(1-2):164-72. PubMed ID: 18395369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of Pseudomonas isolates from the ears and skin of dogs to enrofloxacin, marbofloxacin, and ciprofloxacin.
    Wildermuth BE; Griffin CE; Rosenkrantz WS; Boord MJ
    J Am Anim Hosp Assoc; 2007; 43(6):337-41. PubMed ID: 17975216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
    Jerzsele Á; Pásztiné-Gere E
    Acta Microbiol Immunol Hung; 2015 Mar; 62(1):45-55. PubMed ID: 25823453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and antibiotic susceptibility of bacterial isolates from dogs with otitis externa in Australia.
    Bugden DL
    Aust Vet J; 2013; 91(1-2):43-6. PubMed ID: 23356371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial testing of selected fluoroquinolones against Pseudomonas aeruginosa isolated from canine otitis.
    McKay L; Rose CD; Matousek JL; Schmeitzel LS; Gibson NM; Gaskin JM
    J Am Anim Hosp Assoc; 2007; 43(6):307-12. PubMed ID: 17975212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and antimicrobial susceptibility of bacteria and yeasts isolated from healthy dogs and dogs with otitis externa.
    Lyskova P; Vydrzalova M; Mazurova J
    J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):559-63. PubMed ID: 18045339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance, integron carriage, and gyrA and gyrB mutations in Pseudomonas aeruginosa isolated from dogs with otitis externa and pyoderma in Brazil.
    Arais LR; Barbosa AV; Carvalho CA; Cerqueira AM
    Vet Dermatol; 2016 Apr; 27(2):113-7e31. PubMed ID: 26833540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
    Trott DJ; Moss SM; See AM; Rees R
    Aust Vet J; 2007 Nov; 85(11):464-6. PubMed ID: 17970852
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibacterial susceptibility patterns of Pseudomonas strains isolated from chronic canine otitis externa.
    Martín Barrasa JL; Lupiola Gómez P; González Lama Z; Tejedor Junco MT
    J Vet Med B Infect Dis Vet Public Health; 2000 Apr; 47(3):191-6. PubMed ID: 10829573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and antimicrobial susceptibility patterns of bacteria causing otitis externa in dogs.
    Zamankhan Malayeri H; Jamshidi S; Zahraei Salehi T
    Vet Res Commun; 2010 Jun; 34(5):435-44. PubMed ID: 20526674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on antimicrobial susceptibilities of bacterial isolates from canine and feline otitis externa.
    Hariharan H; Coles M; Poole D; Lund L; Page R
    Can Vet J; 2006 Mar; 47(3):253-5. PubMed ID: 16604982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM; Gibbs PS; Wooley RE
    Vet Ther; 2002; 3(4):493-500. PubMed ID: 12584687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of laboratory identification and antibiotic susceptibility reporting of Pseudomonas spp. isolates from dogs with chronic otitis externa.
    Schick AE; Angus JC; Coyner KS
    Vet Dermatol; 2007 Apr; 18(2):120-6. PubMed ID: 17355427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New combination for the therapy of canine otitis externa. I. Microbiology of otitis externa.
    Kiss G; Radványi S; Szigeti G
    J Small Anim Pract; 1997 Feb; 38(2):51-6. PubMed ID: 9065882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.
    Teresa Tejedor M; Martín JL; Navia M; Freixes J; Vila J
    Vet Microbiol; 2003 Jul; 94(4):295-301. PubMed ID: 12829383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of microbial isolates and susceptibility patterns from the external ear canal of dogs with otitis externa.
    Graham-Mize CA; Rosser EJ
    J Am Anim Hosp Assoc; 2004; 40(2):102-8. PubMed ID: 15007044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Pseudomonas aeruginosa isolates from dogs and cats in Japan: current status of antimicrobial resistance and prevailing resistance mechanisms.
    Harada K; Arima S; Niina A; Kataoka Y; Takahashi T
    Microbiol Immunol; 2012 Feb; 56(2):123-7. PubMed ID: 22188523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiology and antimicrobial susceptibility of otitis externa: a changing pattern of antimicrobial resistance.
    Heward E; Cullen M; Hobson J
    J Laryngol Otol; 2018 Apr; 132(4):314-317. PubMed ID: 29429416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of minimum inhibitory concentrations for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolated from canine otitis externa.
    von Silva-Tarouca MSE; Wolf G; Mueller RS
    Vet Dermatol; 2019 Apr; 30(2):145-e42. PubMed ID: 30663140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.